Please assess the completion status of the following clinical trial:

Trial Title: Maternal Serum Level of ACTH as a Predictive Marker of Preterm Labor in Patients With Threatened Preterm Labor

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Singleton pregnancy.~* Age between 17 - 35 years.~* Gestational age between 28 and 36 weeks.~* Diagnosis of threatened preterm labor is based on the American College of Obstetricians and Gynaecologists Guidelines (ACOG, 2003): Presence of uterine contractions (at least 4 in 20 minutes or 8 in 60 minutes), Cervical dilation \> 1 and \< 4 cm, and/or Cervical effacement ≥ 80%.~Exclusion Criteria:~* Preterm rupture of membranes.~* Any uterine anomalies or cervical incompetence.~* Chronic illness such as chronic hypertension or kidney disease.~* Diabetes mellitus.~* Abruptio placenta.~* Preeclampsia and HELLP syndrome.~* Fetal anomalies.~* IUGR.~* Smoking.~* Clinical signs of intrauterine infection eg (uterine tenderness, foul vaginal discharge, maternal pyrexia ≥ 38°C and/or maternal leucocytosis).

- Gender: FEMALE
- Minimum Age: 17 Years
- Maximum Age: 35 Years
- Healthy Volunteers: f

Study Arms:
- preterm group (Type: None): pregnant healthy women aged from 17 to 35 who suffered from symptoms of threatened preterm labor in the form of Presence of uterine contractions (at least 4 in 20 minutes or 8 in 60 minutes), Cervical dilation \> 1 and \< 4 cm, and/or Cervical effacement ≥ 80%. collection of blood sample and tocolysis administration will be done this group will deliver preterm (before 37 weeks of gestation)
- full term group (Type: None): pregnant healthy women aged from 17 to 35 who suffered from symptoms of threatened preterm labor in the form of Presence of uterine contractions (at least 4 in 20 minutes or 8 in 60 minutes), Cervical dilation \> 1 and \< 4 cm, and/or Cervical effacement ≥ 80%. collection of blood sample and tocolysis administration will be done this group will deliver full term (after 37 weeks of gestation)

Based on this trial design, predict the completion outcome and termination type (if applicable).